Key result
Remote telemonitoring, implantable hemodynamic devices, and cardiac resynchronization therapy offer potential strategies to reduce hospitalizations and manage advanced heart failure.
This review highlights the potential of remote telemonitoring, implantable hemodynamic devices, and cardiac resynchronization therapy to reduce hospitalizations in advanced heart failure.
Despite evidence based medical and pharmacologic advances the management of heart failure remains challenging, especially in the ambulatory setting. There is an urgent need to develop strategies to reduce hospitalizations and re-admission rates for heart failure in general. This focused review illustrates the potential role for remote telemonitoring and implantable hemodynamic devices to address this significant issue. We also explore the growth of cardiac resynchronization therapy and how it has evolved into another tool in our armamentarium for hemodynamic monitoring.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2011) conducted a review in Advanced Heart Failure. Device Therapy (remote telemonitoring, implantable hemodynamic devices, cardiac resynchronization therapy) was evaluated. Remote telemonitoring, implantable hemodynamic devices, and cardiac resynchronization therapy offer potential strategies to reduce hospitalizations and manage advanced heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: